Gilead Sciences, headquartered in Foster City, California, employs 18,000 people and focuses on developing medicines for HIV, hepatitis, COVID-19, and cancer. Its portfolio includes numerous marketed products and several promising candidates.
GILD has been in the news recently: President Trump announced that 14 of the 17 largest drug manufacturers, including Gilead Sciences, agreed to lower medication prices and invest $150 billion in U.S. drug production. This deal aims to align U.S. drug prices with those in other wealthy nations, addressing concerns about the financial impact on the pharmaceutical industry.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.